CPT® Code 90732

Pneumococcal polysaccharide vaccine, 23-valent (PPSV23), adult or immunosuppressed patient dosage, when administered to individuals 2 years or older, for subcutaneous or intramuscular use

The CPT® Code 90732 refers to the pneumococcal polysaccharide vaccine, specifically the 23-valent formulation (PPSV23). This vaccine is designed for administration to adults or immunosuppressed patients aged two years and older. Unlike immune globulins, which offer short-term, passive immunity, vaccines like PPSV23 provide active, long-term immunity. This is achieved by exposing the recipient's immune system to modified versions of specific bacteria, prompting the immune system to produce its own antibodies. The pneumococcal bacteria are commonly found in the nasal passages and throats of many individuals without causing illness. However, if these bacteria invade the body, they can lead to serious conditions such as pneumococcal pneumonia, bacteremia, and meningitis. Certain populations, including children under five years of age, the elderly, and individuals with compromised immune systems, are particularly vulnerable to these diseases. Pneumococcal disease is notably the leading cause of death from vaccine-preventable illnesses in the United States. The code 90732 specifically reports the administration of the 23-valent pneumococcal vaccine, which can be given either subcutaneously or intramuscularly, and it is important to note that this code solely represents the vaccine product used, without any additional services or procedures associated with its administration.